2021
Lack of Guideline-Directed Medical Therapy in Patients Undergoing Endovascular Procedures for Critical Limb Ischemia
Llanos-Chea F, Jelani QU, Trejo-Paredes C, Curtis JP, Parzynski CS, Huang J, Faridi KF, Turner J, Smolderen KG, Mena-Hurtado C. Lack of Guideline-Directed Medical Therapy in Patients Undergoing Endovascular Procedures for Critical Limb Ischemia. Journal Of The American College Of Cardiology 2021, 77: 1374-1375. PMID: 33706882, DOI: 10.1016/j.jacc.2020.12.063.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsCohort StudiesEndovascular ProceduresFemaleGuideline AdherenceHumansHydroxymethylglutaryl-CoA Reductase InhibitorsIschemiaMaleMiddle AgedPeripheral Arterial DiseasePlatelet Aggregation InhibitorsImpact of insurance status on ICD implantation practice patterns: Insights from the NCDR ICD registry
Ahmed I, Merchant FM, Curtis JP, Parzynski CS, Lampert R. Impact of insurance status on ICD implantation practice patterns: Insights from the NCDR ICD registry. American Heart Journal 2021, 235: 44-53. PMID: 33503408, DOI: 10.1016/j.ahj.2021.01.016.Peer-Reviewed Original ResearchConceptsOptimal medical therapyInsurance statusNCDR ICD RegistryMedical therapyComplication rateICD RegistryUninsured patientsCardiac resynchronization therapy defibrillatorPrivate insurancePropensity-weighted analysisSingle-chamber devicesPrimary preventionMean ageICD implantsPractice patternsTreatment weightingImplantation practicePatientsInverse probabilityTherapyInsurance coverageFurther studiesRegistryMedicareStatus
2019
Quadripolar versus bipolar leads in cardiac resynchronization therapy: An analysis of the National Cardiovascular Data Registry
Hakemi EU, Doukky R, Parzynski CS, Curtis JP, Madias C. Quadripolar versus bipolar leads in cardiac resynchronization therapy: An analysis of the National Cardiovascular Data Registry. Heart Rhythm 2019, 17: 81-89. PMID: 31369870, DOI: 10.1016/j.hrthm.2019.07.028.Peer-Reviewed Original ResearchConceptsCardiac resynchronization therapyNational Cardiovascular Data RegistryClinical outcomesResynchronization therapyData registryLong-term clinical outcomesStimulation rateSignificant differencesCongestive heart failure admissionsMedicaid ServicesCRT device implantsHeart failure admissionsProcedural complication rateCRT implantationElderly patientsComplication ratePrimary outcomePlacement failureDevice implantsDevice malfunctionOutcomesPatientsBipolar leadsRegistryTherapyDURATION OF ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS ON ORAL ANTICOAGULANTS IN CLINICAL PRACTICE
Tobolski J, Abbott J, Kolte D, Curtis J, Hira R, Wang Y, Minges K. DURATION OF ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS ON ORAL ANTICOAGULANTS IN CLINICAL PRACTICE. Journal Of The American College Of Cardiology 2019, 73: 1081. DOI: 10.1016/s0735-1097(19)31688-2.Peer-Reviewed Original Research
2017
QUADRIPOLAR VERSUS BIPOLAR LEFT VENTRICULAR LEADS IN CARDIAC RESYNCHRONIZATION THERAPY: AN ANALYSIS FROM THE NCDR
Hakemi E, Doukky R, Parzynski C, Curtis J, Madias C. QUADRIPOLAR VERSUS BIPOLAR LEFT VENTRICULAR LEADS IN CARDIAC RESYNCHRONIZATION THERAPY: AN ANALYSIS FROM THE NCDR. Journal Of The American College Of Cardiology 2017, 69: 335. DOI: 10.1016/s0735-1097(17)33724-5.Peer-Reviewed Original Research
2015
COMPARATIVE EFFECTIVENESS OF CARDIAC RESYNCHRONIZATION THERAPY WITH DEFIBRILLATOR VERSUS DEFIBRILLATOR ALONE IN HEART FAILURE PATIENTS WITH MODERATE TO SEVERE CHRONIC KIDNEY DISEASE
Friedman D, Singh J, Curtis J, Tang W, Bao H, Spatz E, Hernandez A, Patel U, Al-Khatib S. COMPARATIVE EFFECTIVENESS OF CARDIAC RESYNCHRONIZATION THERAPY WITH DEFIBRILLATOR VERSUS DEFIBRILLATOR ALONE IN HEART FAILURE PATIENTS WITH MODERATE TO SEVERE CHRONIC KIDNEY DISEASE. Journal Of The American College Of Cardiology 2015, 65: a452. DOI: 10.1016/s0735-1097(15)60452-1.Peer-Reviewed Original Research
2014
SEX-SPECIFIC MORTALITY RISK BY QRS MORPHOLOGY AND DURATION IN PATIENTS RECEIVING CARDIAC RESYNCHRONIZATION THERAPY: RESULTS FROM THE NCDR®
Zusterzeel R, Curtis J, Canos D, Sanders W, Selzman K, Pina I, Spatz E, Bao H, Ponirakis A, Varosy P, Masoudi F, Strauss D. SEX-SPECIFIC MORTALITY RISK BY QRS MORPHOLOGY AND DURATION IN PATIENTS RECEIVING CARDIAC RESYNCHRONIZATION THERAPY: RESULTS FROM THE NCDR®. Journal Of The American College Of Cardiology 2014, 63: a719. DOI: 10.1016/s0735-1097(14)60719-1.Peer-Reviewed Original Research
2008
Ethnic and racial disparities in cardiac resynchronization therapy
Farmer SA, Kirkpatrick JN, Heidenreich PA, Curtis JP, Wang Y, Groeneveld PW. Ethnic and racial disparities in cardiac resynchronization therapy. Heart Rhythm 2008, 6: 325-331. PMID: 19251206, DOI: 10.1016/j.hrthm.2008.12.018.Peer-Reviewed Original ResearchConceptsCardiac resynchronization therapyHispanic patientsResynchronization therapyWhite patientsNational Cardiovascular Data Registry ICD RegistryMultivariate logistic regression modelAdvanced heart failureTreatment of patientsEthnic differencesLogistic regression modelsICD RegistryHeart failureRegistry participantsGuideline useInclusion criteriaUse of CRTEligibility criteriaPatientsMultivariate analysisRacial disparitiesTherapyOutcome variablesSubstantial proportionRacial differencesRegression modelsDelay in Presentation and Reperfusion Therapy in ST-Elevation Myocardial Infarction
Ting HH, Bradley EH, Wang Y, Nallamothu BK, Gersh BJ, Roger VL, Lichtman JH, Curtis JP, Krumholz HM. Delay in Presentation and Reperfusion Therapy in ST-Elevation Myocardial Infarction. The American Journal Of Medicine 2008, 121: 316-323. PMID: 18374691, PMCID: PMC2373574, DOI: 10.1016/j.amjmed.2007.11.017.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAngioplasty, Balloon, CoronaryEarly DiagnosisElectrocardiographyEmergency Medical ServicesEmergency Service, HospitalFemaleFollow-Up StudiesHospital MortalityHumansMaleMiddle AgedMultivariate AnalysisMyocardial InfarctionMyocardial RevascularizationOdds RatioProbabilityRegistriesRetrospective StudiesRisk FactorsSurvival AnalysisThrombolytic TherapyTime FactorsTreatment OutcomeConceptsST-elevation myocardial infarctionReperfusion therapyHospital presentationBalloon timeSymptom onsetLonger doorMyocardial infarctionDrug timePrimary reperfusion therapyCohort studyLate presentersNeedle timeNational registryPatientsReduced likelihoodTherapyInfarctionLong delayPresentationOnsetHoursAssociationMinutesRegistry
2007
Impact of Delay in Door-to-Needle Time on Mortality in Patients With ST-Segment Elevation Myocardial Infarction
McNamara RL, Herrin J, Wang Y, Curtis JP, Bradley EH, Magid DJ, Rathore SS, Nallamothu BK, Peterson ED, Blaney ME, Frederick P, Krumholz HM. Impact of Delay in Door-to-Needle Time on Mortality in Patients With ST-Segment Elevation Myocardial Infarction. The American Journal Of Cardiology 2007, 100: 1227-1232. PMID: 17920362, PMCID: PMC2715362, DOI: 10.1016/j.amjcard.2007.05.043.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overArrhythmias, CardiacCaliforniaCohort StudiesEmergency Service, HospitalEmergency TreatmentFemaleFibrinolytic AgentsHospital MortalityHumansMaleMedical RecordsMyocardial InfarctionOutcome Assessment, Health CareRegistriesRetrospective StudiesThrombolytic TherapyTime and Motion StudiesTime FactorsConceptsST-segment elevation myocardial infarctionElevation myocardial infarctionNeedle timeFibrinolytic therapyMyocardial infarctionHospital mortalitySymptom onsetOdds ratioReperfusion strategyAdjunctive medicationsHospital arrivalShorter doorTimely administrationNational registryRepresentative cohortPatientsMortalityInfarctionTherapyIndependent effectsCohortMinutesSmaller centersOnsetImpact of delay
2005
Relationship Between Time of Day, Day of Week, Timeliness of Reperfusion, and In-Hospital Mortality for Patients With Acute ST-Segment Elevation Myocardial Infarction
Magid DJ, Wang Y, Herrin J, McNamara RL, Bradley EH, Curtis JP, Pollack CV, French WJ, Blaney ME, Krumholz HM. Relationship Between Time of Day, Day of Week, Timeliness of Reperfusion, and In-Hospital Mortality for Patients With Acute ST-Segment Elevation Myocardial Infarction. JAMA 2005, 294: 803-812. PMID: 16106005, DOI: 10.1001/jama.294.7.803.Peer-Reviewed Original ResearchMeSH KeywordsAdultAfter-Hours CareAgedAged, 80 and overAngioplasty, Balloon, CoronaryBenchmarkingChronology as TopicFemaleHospital MortalityHospitalsHumansMaleMiddle AgedMyocardial InfarctionMyocardial ReperfusionRegistriesRetrospective StudiesThrombolytic TherapyTime and Motion StudiesTime FactorsUnited StatesUtilization ReviewConceptsST-segment elevation myocardial infarctionPercutaneous coronary interventionElevation myocardial infarctionBalloon timeFibrinolytic therapyHospital mortalityMyocardial infarctionAcute ST-segment elevation myocardial infarctionDrug timeRegular hoursTimeliness of reperfusionIn-Hospital MortalityDay of weekPCI patientsReperfusion therapyCohort studyCoronary interventionMean doorHospital characteristicsCatheterization laboratoryBetter outcomesPatientsHospital subgroupsTherapyPatient arrival
2004
Adverse Effects of β-Blocker Therapy for Patients With Heart Failure: A Quantitative Overview of Randomized Trials
Ko DT, Hebert PR, Coffey CS, Curtis JP, Foody JM, Sedrakyan A, Krumholz HM. Adverse Effects of β-Blocker Therapy for Patients With Heart Failure: A Quantitative Overview of Randomized Trials. JAMA Internal Medicine 2004, 164: 1389-1394. PMID: 15249347, DOI: 10.1001/archinte.164.13.1389.Peer-Reviewed Original ResearchMeSH KeywordsAdrenergic beta-AntagonistsAgedBisoprololBradycardiaCarbazolesCarvedilolDizzinessFatigueFemaleFollow-Up StudiesHeart Conduction SystemHeart FailureHumansHypotensionMaleMetoprololMiddle AgedPropanolaminesRisk FactorsRisk Reduction BehaviorSeverity of Illness IndexStatistics as TopicTreatment FailureVentricular Dysfunction, LeftWithholding TreatmentConceptsBeta-blocker therapyHeart failureAdverse effectsLeft ventricular systolic dysfunctionBeta-blocker trialsCardiovascular adverse effectsChronic heart failureHeart Failure TrialVentricular systolic dysfunctionΒ-blocker therapyRisk of hypotensionLife-saving therapyRandom-effects modelHF hospitalizationCause mortalitySystolic dysfunctionCause withdrawalsFailure TrialRandomized trialsAbsolute riskElectronic searchPatientsMEDLINE databaseTherapyAbsolute increase
2003
Spontaneous Coronary Artery Dissection in a Woman Receiving 5-Fluorouracil
Abbott JD, Curtis JP, Murad K, Kramer HM, Remetz MS, Setaro JF, Brennan JJ. Spontaneous Coronary Artery Dissection in a Woman Receiving 5-Fluorouracil. Angiology 2003, 54: 721-724. PMID: 14666962, DOI: 10.1177/000331970305400613.Peer-Reviewed Case Reports and Technical NotesConceptsSpontaneous coronary artery dissectionCoronary artery dissectionArtery dissectionMyocardial infarctionAcute ST-elevation myocardial infarctionST-elevation myocardial infarctionLeft anterior descending (LAD) arteryExtensive coronary dissectionAnterior descending (LAD) arteryPelvic radiation therapyCoronary dissectionPelvic radiationCoronary angiographyIntractable vomitingThrombolytic therapyCervical cancerHormonal changesRadiation therapyHemodynamic stressDissectionVomitingTherapyWomenVasospasmStenting
2002
Clinical trials do not support strong association of beta-blocker therapy with fatigue, depression, or sexual dysfunction
Ko D, Hebert P, Coffey C, Sedrakyan A, Curtis J, Krumholz H. Clinical trials do not support strong association of beta-blocker therapy with fatigue, depression, or sexual dysfunction. Journal Of The American College Of Cardiology 2002, 39: 440. DOI: 10.1016/s0735-1097(02)81978-7.Peer-Reviewed Original Research